Skip to main content
. Author manuscript; available in PMC: 2019 Dec 18.
Published in final edited form as: J Urol. 2018 Mar 26;200(1):187–194. doi: 10.1016/j.juro.2018.02.3101

Table 3.

Bladder management and continence outcomes by SB type

Age Group Overall/Total No. (%) P Value
(chi-square test)

5 –11 Yrs 12 –19 Yrs 20 Yrs or Older

No. pts 1,993 1,885    1,372 5,250/5,250 (100)
No. bladder management by CIC (%):
 Myelomeningocele 1,141 (77.1) 1,261 (83.8) 937 (79.5) 3,339/4,193 (80.2) <0.0001
 Nonmyelomeningocele 138 (27.9) 174 (47.3) 110 (59.5) 422/1,057 (40.3) <0.0001
No. bladder continence (%):
 Myelomeningocele 432 (29.0) 638 (42.1) 543 (45.8) 1,613/4,193 (38.5) <0.0001
 Nonmyelomeningocele 304 (60.7) 249 (67.5) 118 (63.1) 671/1,057 (63.5)   0.1192
 All pts 736 (36.9) 887 (47.1) 661 (48.2) 2,284/5,250 (43.5) <0.0001